Back to search
Hyperinsulinism-Hyperammonemia Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hyperinsulinism-Hyperammonemia Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hyperinsulinism-Hyperammonemia Syndrome trials you may qualify forNewborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple…
Congenital Portosystemic Shunt (CPSS) is a rare condition important by the multiplicity and severity of associated complications. CPSS is venous anomaly in whi…
Early Check provides voluntary screening of newborns for a selected panel of conditions. The study has three main objectives: 1) develop and implement an approa…
Congenital hyperinsulinism (HI) is a rare disorder of pancreatic beta cell insulin secretion that causes persistent and severe hypoglycemia starting at birth. H…
Investigators will assess the tolerability of oral Vitamin E supplementation in subjects with congenital hyperinsulinism (HI) and hyperammonemia (HA) syndrome.
The purpose of this study is to determine if there is a significant percentage of children with the diagnosis of idiopathic seizures who have undiagnosed or unr…